A Century-Old Legacy Sets Sail: Three "SPH Long Hu" Products from SPH Zhonghua Secure Canadian Market Authorization!

Recently, three core products from Shanghai Pharma Zhonghua — Qingliang You (Regular), Qingliang You (Ultra), and Fengyou Jing Oil (Roll-on) — officially received Natural Health Product (NHP) licenses from Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD). Securing these three licenses marks a critical breakthrough in gaining market access to North America, laying a solid regulatory foundation for the brand's expansion into the region!

The three approved products blend classic heritage with innovative upgrades, offering benefits such as cooling relief, mental refreshment, and the alleviation of minor aches and pains—making them summer essentials for consumers. The "Ultra" version of the cooling balm features an optimized formula that delivers longer-lasting cooling and soothing effects. In addition to cooling and refreshing, the roll-on Fengyou Jing helps soothe muscle and joint soreness.

Canada’s pharmaceutical regulatory system commands immense credibility and influence. Obtaining NNHPD product licenses means that Longhu Cooling Balm and Fengyou Jing have gained official certification and the qualifications to enter the North American market. This represents not only a market breakthrough but also a significant leap in the brand's international value—marking a transition for the century-old "Longhu" brand from mere "product export" to "recognition of standards.

Leveraging its century-long heritage, Shanghai Pharma Zhonghua remains committed to an internationalization strategy of "going global." The company pioneered the registration of its cooling balm with Hong Kong's Traditional Chinese Medicine authorities back in 2012, and compliance registration for key products like Fengyou Jing and Rendan in Hong Kong is currently proceeding steadily. Beyond Hong Kong, the brand is actively pursuing a global footprint, focusing on high-potential overseas markets such as Southeast Asia and North America. By continuously conducting market research, preparing for regulatory compliance, and establishing distribution channels, the company is building a robust foundation for long-term success and deep market penetration abroad. 

 

 

This successful market entry into Canada marks a significant milestone in Shanghai Pharma Zhonghua’s internationalization strategy and serves as a fresh starting point for deepening the brand's presence in overseas markets. Moving forward, the company remains steadfast in its core development philosophy—prioritizing scientific pharmaceutical practices, quality assurance, and regulatory compliance. With the North American market serving as a strategic breakthrough, the company will continue to steadily advance its global expansion, bringing high-quality products rooted in Eastern herbal wisdom to households worldwide and writing a new chapter for Chinese health brands going global.